Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study)

Autor: Lourdes Albert-Botella, María Dolores Rodríguez Mulero, Leonor Nogales Martín, María José Fora Romero, Lucía Fernández Presa, Luis García de Guadiana-Romualdo, María Dolores Calvo, Marta Hernández Olivo, Ana Belen López Tarazaga, Isabel Llompart-Alabern, Cristina Bolado Jiménez, Edwin R Puerto-Lara, Leyre Pinilla Arribas, Celia Juez Santamaría, María Galindo Martínez, Aleksandra Mandic Havelka, Andrea Ballester Férriz, Valerio Campos-Rodríguez, Enrique Rodríguez-Borja, María Dolores Albaladejo-Otón, Carlos Rodríguez Rojas, Virginia Espinilla Fernández, Alexandra M Guiu-Martí, María Salomé Ros Braquehais, Wysalli Trapiello Fernández, Adela Pozo Giraldez, David Andaluz-Ojeda, Daniel Morell-Garcia, Juan Ortega-Pérez, Antonieta Ballesteros-Vizoso

Publikováno v: Inflammation Research
Inflammation research : official journal of the European Histamine Research Society ... [et al.]
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

OBJECTIVE: Severe COVID-19 is characterized by a dysregulated immune response in which neutrophils play a critical role. Calprotectin reflects neutrophil activation and is involved in the self-amplifying thrombo-inflammatory storm in severe COVID-19.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97accf78dc7422286b31293dddaba3e1
https://doi.org/10.1007/s00011-021-01516-4